LATE BREAKING ABSTRACT DEADLINE – (NO EXTENSIONS)
11.59 am Midday AEST Monday 16 August 2021
If you missed the chance to submit an abstract in the first round due to incomplete data, or you have exciting new research, this is your last chance to be included in a fantastic program filled with internationally distinguished speakers and innovative research and clinical practice.
The Late Breaking sessions are informative fast-paced 5-minute presentations. The sessions are dedicated to new information or important findings not fully available before the general abstract deadline. Presentations are five minutes and should have no more than five slides. This session is one of the most popular sessions at the conference and will be live streamed for Virtual attendees.
Late Breaking presentations are held in a single stream, this is an opportunity to present to all conference delegates, and is a popular session with delegates at the conference.
Late Breaker Abstract Submissions Open on Monday 19 July.
Late Breaking Abstract Deadline: 11.59 am Midday AEST Monday 16 August 2021 (NO EXTENSIONS)
Please note that the Late Breaking Abstract deadline is not an extension of the general abstract submission deadline.
In order to standardise the abstract layout, we kindly ask you to read the abstract submission guidelines carefully and use the abstract template provided.
Notification regarding late breaking abstract’s status (accepted or rejected) will be sent to the presenting author of the abstract by Monday 20 September 2021.
Abstracts will be accepted for oral and e-poster late breaking presentations.
Late Breaking Prize
APSAD has a sponsored prize for best Late Breaking Presentation delivered at the Conference. The presenter judged as preparing and delivering the Best Late Breaking Presentation receives a certificate and a book voucher valued at $100. The award will be announced at the closing session of the conference.
There will also be certificates for the runner up and an honourable.
The Late Breaking Presentations are judged on the basis of original scientific importance or clinical or policy relevance, and clarity of presentation.
Late Breaking Abstract Submission Instructions
Presentation Types
The Scientific Advisory Committee welcomes the submission of Late Breaking Abstracts for presentation at the APSAD 2021 Brisbane Hybrid Conference for the following presentation types;
Oral Presentations
Time Allocated: 5 minutes | 5 slide maximum
Description: Oral presentations on original research findings, case studies, completed projects and theoretical analyses. Presentations should be well structured, rigorous and demonstrate a novel contribution to knowledge.
e-Poster Presentations
Time Allocated: e-Posters will be digital and all poster presenters will have the option of recording a 3-minute audio presentation to be included with the e-Poster.
Description: e-Posters can present research, case studies, divisional projects, or clinical topics.
Practice Based/Service Delivery Oral Presentations
Time Allocated: 5 minutes | 5 slide maximum | In person and virtual
Description: Oral presentations analysing issues and solutions to problems in clinical practice, community engagement, education, health promotion and policy. Presentations should be well structured, rigorous and demonstrate a novel contribution to knowledge.
The session is dedicated to late-breaking and unpublished findings and cannot be a revision of an abstract submitted during the general abstract submission process. Late Breaking abstracts, containing new information or important findings not (fully) available before the general abstract deadline, can be submitted until midday Monday 16 August 2021. For information regarding types of presentations and abstract preparation guidelines please see the abstract guidelines.
Please note that the Late Breaking Abstract deadline is not an extension of the general abstract submission deadline.
Abstracts must be submitted by 11.59am Midday AEST Monday 16 August 2021, there will be no extension to the submission closing date.
Abstract Templates
Abstracts must be submitted using the appropriate abstract template, please see the template options below;
Please read the abstract guidelines carefully. Any abstracts that do not conform to the guidelines will not be considered.
The Scientific Advisory Committee may reallocate a presentation type on the basis of time, content, space available and applicability to the Conference themes.
Note: Abstract presenters will be required to fund their own attendance at the conference and should not submit an abstract if this is not possible.
Disclosure of Interest / Ethical Statement
APSAD recognises the considerable contribution that industry partners make to professional and research activities. We also recognise the need for transparency of disclosure of potential conflicts of interest by acknowledging these relationships in publications and presentations.
For an example of a disclosure of interest/ethical statement please see below
Dr Smith has received funding from Metabolism Corp. No pharmaceutical grants were received in the development of this study.
Note: If accepted into the program you will be requested to include a disclosure of interest slide into your presentation or include such statements in your e-poster.
Selection Criteria
Abstracts will be favoured at review if they incorporate:
- Completed rather than future work (i.e., final results)
- Original data of high quality.
- An analysis that extends existing knowledge
- Clarity of methodology, analysis and presentation of results
- Specific rather than general findings
In balancing the program, the committee may require authors to present their work in an alternate format (e.g., as a poster rather than oral presentation).
Note: We encourage abstracts that are based on Indigenous issues be presented by Indigenous persons, or an Indigenous co-presenter be included. If this is not possible, please include some information as to whether any member of the Indigenous community in which the research is based was involved in development of the research protocol or in conducting the research. Where possible this applies to other population groups as well.
Themes for Submission
Authors must select one primary and one secondary theme of the following that their abstract relates to.
Addiction Reconceptualised
Adolescents / Youth
Aetiology (Incl. Genetics)
Alcohol
Blood-Borne Viruses (Incl. STI)
Cannabis
Children & Families
Coercive Treatment
Cognitive Impairment Training
Comorbidity
Consumers & Peers
COVID-19
Crime, Justice, & Legal Issues
Cross Culture & International
Drug Monitoring / Novel Psychoactive
Drug Policy Reform
Ecstasy & Emerging Psychoactive Substances
E-Health – Behavioural Change
Epidemiology
First Peoples
Gambling
Harms & Harm Reduction
Health Policy & Reforms
Health, Law & Human Rights
Health Services & Systems
Heroin & Opioids
Injecting Drug Use
Innovative Prescribing: Medicinal Cannabis, E-Cigs, etc.
LGBTIQ
Methamphetamine & Psychostimulants
Neuroscience
New Technologies & E-Interventions
Older Adults
Other AOD Issues
Overdose
Over The Counter Codeine Rescheduling
Pharmaceuticals (Consumption)
Prescription Opioid Treatment
Prevention & Early Intervention
Primary Care – Pharmacy in Primary Care
Prisons & Prisoner Health
Psychopharmacology & Psychobiology
Regional Challenges & Innovations
Social & Community Issues
Special Populations
Tobacco & Tobacco Cessation
Translational Research
Treatment Settings
Treatment & Interventions
Well At Work
Women & Maternal Issues
Workforce Issues
Notification of Acceptance
Notifications of acceptance will be sent via e-mail to the submitting author by Monday 20 September 2021. Abstracts submitted for oral will also be considered and reviewed for an e-poster presentation.